The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACHILLES THERAPEUTICS PLC | SPONSORED ADS | 00449L102 | 2,987,563 | 2,390,050 | SH | DFND | 2 | 0 | 2,390,050 | 0 | |
DYNE THERAPEUTICS INC | COM | 26818M108 | 182,172,753 | 6,416,793 | SH | DFND | 2 | 0 | 6,416,793 | 0 | |
DYNE THERAPEUTICS INC | COM | 26818M108 | 40,557,131 | 1,428,571 | SH | DFND | 0 | 1,428,571 | 0 | ||
ENGENE HOLDINGS INC | COM | 29286M105 | 98,034,596 | 5,783,752 | SH | DFND | 1 | 0 | 5,783,752 | 0 | |
ENGENE HOLDINGS INC | W EXP 10/31/2028 | 29286M113 | 12,495,974 | 2,403,072 | SH | DFND | 1 | 0 | 2,403,072 | 0 | |
ENGENE HOLDINGS INC | COM | 29286M105 | 49,056,673 | 2,894,199 | SH | DFND | 0 | 2,894,199 | 0 | ||
ENGENE HOLDINGS INC | W EXP 10/31/2028 | 29286M113 | 2,470,395 | 475,076 | SH | DFND | 0 | 475,076 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 122,887,056 | 5,196,070 | SH | DFND | 1 | 0 | 5,196,070 | 0 | |
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 156,926,997 | 6,635,391 | SH | DFND | 2 | 0 | 6,635,391 | 0 | |
REPLIMUNE GROUP INC | COM | 76029N106 | 39,758,888 | 4,866,449 | SH | DFND | 0 | 4,866,449 | 0 |